Hyogo, Japan

Kaoru Seno


 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 215(Granted Patents)


Location History:

  • Nishinomiya, JP (1998 - 1999)
  • Hyogo, JP (1989 - 2000)
  • Osaka, JP (2005 - 2010)

Company Filing History:


Years Active: 1989-2010

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Kaoru Seno**

Introduction

Kaoru Seno is a prominent inventor based in Hyogo, Japan, who has made significant contributions to the field of pharmaceuticals. With an impressive portfolio that includes 14 patents, Seno has dedicated his career to the exploration and development of innovative compounds aimed at addressing critical health issues.

Latest Patents

Among his latest inventions, Seno has developed a pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor. This compound is represented by the formula (Ia), where R1, R2, R3 to R5 are specifically defined within the accompanying description. These compounds aim to prevent or treat diseases associated with NAD(P)H, showcasing their potential in the therapeutic landscape. Another noteworthy patent includes a compound characterized by a general formula, where R varies in structure, such as -CHCOOH, -COCONH, or C4–C6 alkyl groups. This compound has been identified as having sPLA inhibitory effects, adding to the therapeutic possibilities in the field.

Career Highlights

Kaoru Seno works with Shionogi & Company Limited, a well-respected entity in the pharmaceutical industry. His career is marked by relentless innovation and a commitment to advancing medical science through his patents and scientific work.

Collaborations

Throughout his work, Seno has collaborated with notable colleagues, including Sanji Hagishita and Susumu Kamata. These partnerships have likely fostered an environment of shared ideas and breakthroughs, amplifying the impact of their research in the pharmaceutical domain.

Conclusion

Kaoru Seno's contributions to pharmaceutical innovations through his patents exemplify his dedication to improving healthcare outcomes. With a solid foundation built on collaboration and a focus on groundbreaking discoveries, he continues to be a pivotal figure in the fight against diseases relating to NAD(P)H.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…